Olivia Tan
BSc in Science (Physiology, Pharmacology and Chemistry) | MSc in Biomedical and Health Sciences
Olivia always had a persisting curiosity in the sciences; this was demonstrated through her career switch from business development to the biomedical research field where she identified her keen interest in cardiovascular sciences at Monash University.
Olivia is currently working on unravelling the complex pathophysiology of heart failure with preserved ejection fraction (HFpEF) in a novel animal model under the guidance of Associate Professor Bing Hui Wang and Professor David Kaye. Although HFpEF received less attention than its counterpart, heart failure with reduced ejection fraction (HFrEF), is currently the most common form of heart failure. However, there is limited targeted treatment currently available for HFpEF in part due to the lack of a clinically relevant animal model.
Olivia aims to embody the 3Cs:
- Curiosity: to solve novel, difficult problems such as HFpEF
- Courage: to tackle what remains unknown
- Creativity: in problem solving so as to make an impactful contribution to the field and in the Heart Failure Research lab in her journey as a young researcher.
Olivia is thrilled to be surrounded by individuals who are passionate in researching cardiovascular sciences and industry leaders who are constantly pushing the boundaries of scientific knowledge at the Baker Institute. Olivia is excited to learn and improve during her time at Baker Institute.